Your browser doesn't support javascript.
loading
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD).
Maher, Toby M; Assassi, Shervin; Azuma, Arata; Cottin, Vincent; Hoffmann-Vold, Anna-Maria; Kreuter, Michael; Oldham, Justin M; Richeldi, Luca; Valenzuela, Claudia; Wijsenbeek, Marlies S; Coeck, Carl; Schlecker, Christina; Voss, Florian; Wachtlin, Daniel; Martinez, Fernando J.
Afiliação
  • Maher TM; Department of Pulmonary, Critical Care and Sleep Medicine, University of Southern California Keck School of Medicine, Los Angeles, California, USA tobymahe@usc.edu.
  • Assassi S; Section of Inflammation, Repair and Development, Imperial College London National Heart and Lung Institute, London, UK.
  • Azuma A; Division of Rheumatology, University of Texas McGovern Medical School, Houston, Texas, USA.
  • Cottin V; Pulmonary Medicine and Oncology, Nippon Medical School, Tokyo, Japan.
  • Hoffmann-Vold AM; Respiratory Medicine and Clinical Research Centre, Meisei Hospital, Saitama, Japan.
  • Kreuter M; Service de pneumologie, Hôpital Louis Pradel, Centre de Référence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, iNRAE, member of ERN-LUNG, Lyon, France.
  • Oldham JM; Department of Rheumatology, Oslo University Hospital, Oslo, Norway.
  • Richeldi L; Center for Interstitial and Rare Lung Diseases, Department of Pneumology, Thoraxklinik, University of Heidelberg, Member of the German Center for Lung Research, Heidelberg, Germany.
  • Valenzuela C; Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Wijsenbeek MS; Unità Operativa Complessa di Pneumologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Coeck C; ILD Unit, Pulmonology Department, Hospital Universitario de la Princesa, University Autonomade Madrid, Madrid, Spain.
  • Schlecker C; Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Voss F; Boehringer Ingelheim SComm, Brussels, Belgium.
  • Wachtlin D; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
  • Martinez FJ; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.
BMJ Open Respir Res ; 10(1)2023 09.
Article em En | MEDLINE | ID: mdl-37709661
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Idiopática Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Idiopática Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos